Tom Hollon (“Metspalu Puts Estonia on the Genomics Map,” p. 22), is a science writer and editor in Rockville, Md. He was the founding editor of Modern Drug Discovery magazine and conducted research at the National Institutes of Health, the Pasteur Institute, and the University of Washington. His articles have appeared in The Scientist, Nature Medicine, Nature Biotechnology, and The Lancet. Contact him at [email protected]
William Langbein (“Pathogen Genome Labs Primed for Push,” p. 34) is a science and business writer based in Berkeley, Calif. He first wrote about genome therapeutics in 1993, covering companies such as Sequana, Millennium, and also SmithKline Beecham’s then-radical $120 million capitalization of The Institute for Genomic Research. A westward move a few years later took him to California Medicine magazine and other publications before he began writing for Reuters Health last year and learned that $120 million investments in genome technology were no longer excessive.
Illustrator Robert Burger, who created the art for this month’s IT Guy, says the self-portrait shown here reflects his state of mind, if not his likeness. His work has appeared in numerous national and international publications and in the annuals of The Society of Illustrators of New York and the Society of Illustrators of Los Angeles and also in the Graphis Design Annual and Print’s Regional Design Annual. Burger is the recipient of New Jersey State Council on the Arts Design Arts Fellowship in Illustration. When not busy creating illustrations or playing with his two sons, he spends what little free time he has playing guitar with the space-rock band Brainstatik.
Catherine Liden Traugot (“Cogent Eyes Therapeutics for Neurological Disease,” p. 28) is a freelance writer covering technology companies in the Research Triangle Park region of North Carolina. Her articles have appeared in Upside Online, Business North Carolina Magazine, and The Deal. She lives in Cary, NC.